143 related articles for article (PubMed ID: 11552076)
1. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
[TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors.
Haddad S; Leitman SF; Wesley RA; Cecco S; Yau YY; Starling J; Rehak NN; Bolan CD
Transfusion; 2005 Jun; 45(6):934-44. PubMed ID: 15934992
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects.
Bolan CD; Cecco SA; Yau YY; Wesley RA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1414-22. PubMed ID: 14507273
[TBL] [Abstract][Full Text] [Related]
4. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
Mercan D; Bastin G; Lambermont M; Dupont E
Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms.
Bolan CD; Wesley RA; Yau YY; Cecco SA; Starling J; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1403-13. PubMed ID: 14507272
[TBL] [Abstract][Full Text] [Related]
6. Calcium and magnesium levels during automated plateletpheresis in normal donors.
Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
[TBL] [Abstract][Full Text] [Related]
7. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
8. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation.
Bolan CD; Cecco SA; Wesley RA; Horne M; Yau YY; Remaley AT; Childs RW; Barrett AJ; Rehak NN; Leitman SF
Transfusion; 2002 Jul; 42(7):935-46. PubMed ID: 12375668
[TBL] [Abstract][Full Text] [Related]
9. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis.
Toffaletti J; Nissenson R; Endres D; McGarry E; Mogollon G
J Clin Endocrinol Metab; 1985 May; 60(5):874-9. PubMed ID: 3980672
[TBL] [Abstract][Full Text] [Related]
10. Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis.
Garg K; Kaur P; Bedi RK; Gupta S
Transfus Clin Biol; 2021 Aug; 28(3):239-245. PubMed ID: 33965622
[TBL] [Abstract][Full Text] [Related]
11. How to stabilize the level of ionized calcium and citrate during plateletpheresis.
Farrokhi P; Farahmand H; Bismuth A; Suarez C; Ducot B; Gillon MC; Debat P; Laskowski P; Pinon F
Vox Sang; 1998; 74(1):7-12. PubMed ID: 9481853
[TBL] [Abstract][Full Text] [Related]
12. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
Morse EE; Hohnadel DC; Genco P; Katz AJ
Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
[TBL] [Abstract][Full Text] [Related]
13. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
Lokhande T; Thomas S; Kumar G; Bajpai M
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
[TBL] [Abstract][Full Text] [Related]
14. Hypocalcemic symptoms during plateletpheresis using the COBE Spectra: a comparison of oral combination of 600mg calcium+300mg magnesium+100IU vitamin D3 vs. a 1000mg calcium in symptomatic donors.
Palfi M; Martinsson L; Sundström K
Transfus Apher Sci; 2007 Jun; 36(3):291-5. PubMed ID: 17613274
[TBL] [Abstract][Full Text] [Related]
15. Serial monitoring of ionised calcium levels in plateletpheresis donors: A study from tertiary care oncology centre in India.
Navkudkar A; Desai P; Rajadhyaksha S
Transfus Apher Sci; 2022 Jun; 61(3):103350. PubMed ID: 35012841
[TBL] [Abstract][Full Text] [Related]
16. Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.
Kreuzer M; Ahlenstiel T; Kanzelmeyer N; Ehrich JH; Pape L
Pediatr Nephrol; 2010 Jul; 25(7):1305-10. PubMed ID: 20221775
[TBL] [Abstract][Full Text] [Related]
17. Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis.
Toffaletti J
Transfusion; 1983; 23(6):471-5. PubMed ID: 6649022
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypercalcemia on serum concentrations of magnesium, potassium, and phosphate and urinary excretion of electrolytes in horses.
Toribio RE; Kohn CW; Rourke KM; Levine AL; Rosol TJ
Am J Vet Res; 2007 May; 68(5):543-54. PubMed ID: 17472456
[TBL] [Abstract][Full Text] [Related]
19. QTc prolongation in apheresis platelet donors.
Laspina SJ; Browne MA; McSweeney EN; Lawlor J; Whelan DM; Kinsella AL; Murphy WG
Transfusion; 2002 Jul; 42(7):899-903. PubMed ID: 12375663
[TBL] [Abstract][Full Text] [Related]
20. Utilization of a new strength citrate anticoagulant during centrifugal plateletpheresis. I. Assessment of donor effects.
Mishler JM; Janes AW; Lowes B; Farfan C; Emerson PM
Br J Haematol; 1976 Nov; 34(3):387-94. PubMed ID: 990180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
